Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026

Peptide Comparison

PT-141 vs Melanotan I

Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.

This combination is flagged

Melanotan II combined with novel peptides during dose-finding: High risk per peptide research literature. Masks individual peptide response (pigmentation, nausea, BP overlap); MC1R activation raises melanoma/mole darkening concerns when dose-finding other compounds.

Data-derived verdict

PT-141 and Melanotan I share the melanocortin class and carry roughly equivalent evidence (FDA-Approved / FDA/EMA-Approved). On the catalogued data layer PT-141 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; PT-141's evidence base is currently denser.

Generated from catalog evidence-tier data, not editorial judgment. Both compounds share at least one mechanism class and this verdict reads the catalogued evidence tier of each, not specific trial nuance.

Evidence at a glance

PT-141

FDA-Approved

Melanotan I

FDA/EMA-Approved

FDA-approved   Phase 3   Phase 2 / approved abroad   Anecdotal + animal   Preclinical / flagged

Shared safety considerations

Both compounds share these reported concerns: nausea. Open each peptide page for the full risk paragraph and source citations.

Side-by-side

PT-141 Melanotan I
Class Melanocortin receptor agonist (FDA-approved) MC1R agonist; EU/FDA-approved for EPP
Drug class Sexual-Health Dermatologic
Mechanism MC4R agonist in CNS; induces sexual desire independent of vascular mechanisms Selective MC1R agonist; stimulates eumelanin production without sexual effects of MT-II
Route SC / Intranasal SC implant
Half-life ~2 hrs Implant (sustained release)
Dosage (research) 1.75 mg SC 45 min before sex (FDA label) 16 mg SC implant every 2 months
Evidence tier FDA-Approved FDA/EMA-Approved
Research depth 99 indexed (PubMed 84 · CT 4 · EPMC 11) 101 indexed (PubMed 87 · CT 0 · EPMC 14)
Availability Prescription Prescription (EPP)
Reported risks Nausea (~40%); flushing; headache; transient BP increase; focal hyperpigmentation Injection site reactions; fatigue; nausea; melanin darkening

Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.

Frequently asked questions

Should I pick PT-141 or Melanotan I?

PT-141 and Melanotan I share the melanocortin class and carry roughly equivalent evidence (FDA-Approved / FDA/EMA-Approved). On the catalogued data layer PT-141 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; PT-141's evidence base is currently denser.

What is the difference between PT-141 and Melanotan I?

PT-141 is classed as Melanocortin receptor agonist (FDA-approved); Melanotan I is classed as MC1R agonist; EU/FDA-approved for EPP. Reported mechanism: PT-141, MC4R agonist in CNS; induces sexual desire independent of vascular mechanisms; Melanotan I, Selective MC1R agonist; stimulates eumelanin production without sexual effects of MT-II. Reported half-life: PT-141, ~2 hrs; Melanotan I, Implant (sustained release). Routes in published studies: PT-141, SC / Intranasal; Melanotan I, SC implant.

Which has stronger evidence, PT-141 or Melanotan I?

PT-141 and Melanotan I sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. PT-141 is graded FDA-Approved, with 6 cited sources on its reference page and 99 indexed studies. Melanotan I is graded FDA/EMA-Approved, with 2 cited sources on its reference page and 101 indexed studies.

Which is more accessible, PT-141 or Melanotan I?

Both PT-141 and Melanotan I are FDA-approved drugs. Catalog status: PT-141, Prescription; Melanotan I, Prescription (EPP).

Are PT-141 and Melanotan I ever combined?

PT-141 and Melanotan I appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.

Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.

Loading interactive view…